title: Respiratory failure due to Pneumocystis carinii following methotrexate therapy for gestational trophoblastic disease.
authors.affiliation: Department of Intensive Care Unit, CHI Poissy/Saint-Germain-en-Laye, 78105 Saint-Germain-en-Laye, France.
authors.forename: Christophe
authors.initials: C
authors.lastname: Barbier
authors.forename: Leïla
authors.initials: L
authors.lastname: Arnaout
authors.forename: Christophe
authors.initials: C
authors.lastname: Schmit
authors.forename: Jean-Sébastien
authors.initials: JS
authors.lastname: Aucouturier
authors.forename: Jean-Louis
authors.initials: JL
authors.lastname: Ricome
authors.forename: Yann
authors.initials: Y
authors.lastname: Loubières
mesh_terms: D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000378:metabolism; D005260:Female; D006801:Humans; D002820:Hydatidiform Mole, Invasive / Q000097:blood / Q000188:drug therapy; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008727:Methotrexate / Q000009:adverse effects*; D009894:Opportunistic Infections / Q000150:complications* / Q000188:drug therapy; D045363:Pneumocystis carinii; D011020:Pneumonia, Pneumocystis / Q000150:complications* / Q000188:drug therapy; D011247:Pregnancy; D012131:Respiratory Insufficiency / Q000382:microbiology*; D019233:Retreatment; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use; D014594:Uterine Neoplasms / Q000097:blood / Q000188:drug therapy; D014620:Vacuum Extraction, Obstetrical / Q000379:methods
chemical_list: D000890:Anti-Infective Agents; D018997:Chorionic Gonadotropin, beta Subunit, Human; D007166:Immunosuppressive Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D008727:Methotrexate